Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines.

[1]  L. Kwak,et al.  Prime-Boost Vaccination Using Chemokine-Fused gp120 DNA and HIV Envelope Peptides Activates Both Immediate and Long-Term Memory Cellular Responses in Rhesus Macaques , 2010, Journal of biomedicine & biotechnology.

[2]  Jinsong Wei,et al.  Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity. , 2009, Blood.

[3]  J. Winter,et al.  Idiotype vaccine therapy (BiovaxID) in follicular lymphoma in first complete remission: Phase III clinical trial results. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Liu,et al.  IFN-α Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity1 , 2009, The Journal of Immunology.

[5]  M. Bianchi,et al.  Induction of inflammatory and immune responses by HMGB1–nucleosome complexes: implications for the pathogenesis of SLE , 2008, The Journal of experimental medicine.

[6]  Haitao Wen,et al.  TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events , 2008, The Journal of experimental medicine.

[7]  C. Liu,et al.  Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. , 2008, The Journal of clinical investigation.

[8]  Lucia Gabriele,et al.  The feedback phase of type I interferon induction in dendritic cells requires interferon regulatory factor 8. , 2007, Immunity.

[9]  M. Tao,et al.  Development of an effective Japanese encephalitis virus-specific DNA vaccine. , 2006, Microbes and infection.

[10]  Sunil Thomas,et al.  Innate Inflammatory Signals Induced by Various Pathogens Differentially Dictate the IFN-I Dependence of CD8 T Cells for Clonal Expansion and Memory Formation1 , 2006, The Journal of Immunology.

[11]  R. Medzhitov,et al.  Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. , 2006, Immunity.

[12]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[13]  L. Moldawer,et al.  CD11c+ Dendritic Cells Are Required for Survival in Murine Polymicrobial Sepsis1 , 2005, The Journal of Immunology.

[14]  Ross M. Kedl,et al.  Immunization with HIV-1 Gag Protein Conjugated to a TLR7/8 Agonist Results in the Generation of HIV-1 Gag-Specific Th1 and CD8+ T Cell Responses , 2005, The Journal of Immunology.

[15]  J. Curtsinger,et al.  Cutting Edge: Type I IFNs Provide a Third Signal to CD8 T Cells to Stimulate Clonal Expansion and Differentiation1 , 2005, The Journal of Immunology.

[16]  Tak W. Mak,et al.  Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.

[17]  M. Lifton,et al.  Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines. , 2004, The Journal of clinical investigation.

[18]  R. Steinman,et al.  The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation , 2004, The Journal of experimental medicine.

[19]  M. Tao,et al.  In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine. , 2004, Vaccine.

[20]  Zihai Li,et al.  Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[21]  P. Musiani,et al.  Individual Analysis of Mice Vaccinated against a Weakly Immunogenic Self Tumor-Specific Antigen Reveals a Correlation between CD8 T Cell Response and Antitumor Efficacy 1 , 2003, The Journal of Immunology.

[22]  R. Koup,et al.  Toll-Like Receptor Ligands Modulate Dendritic Cells to Augment Cytomegalovirus- and HIV-1-Specific T Cell Responses 1 , 2003, The Journal of Immunology.

[23]  J. Gutiérrez,et al.  Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom , 2003, Muscle & nerve.

[24]  S. Rosenberg,et al.  Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  W. Lindenmaier,et al.  Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen1 , 2003, The Journal of Immunology.

[26]  K. Ozato,et al.  Cutting Edge: IFN Consensus Sequence Binding Protein/IFN Regulatory Factor 8 Drives the Development of Type I IFN-Producing Plasmacytoid Dendritic Cells 1 , 2003, The Journal of Immunology.

[27]  F. Belardelli,et al.  ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α+ Dendritic Cells , 2002, The Journal of experimental medicine.

[28]  L. Kwak,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 , 2002, Science.

[29]  R. Levy,et al.  Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma. , 2002, Cancer research.

[30]  E. Raz,et al.  IFN-αβ Promote Priming of Antigen-Specific CD8+ and CD4+ T Lymphocytes by Immunostimulatory DNA-Based Vaccines1 , 2002, The Journal of Immunology.

[31]  Juan Carlos Vidal,et al.  Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  L. Kwak,et al.  Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens , 2001, The Journal of Immunology.

[33]  Craig W. Reynolds,et al.  Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma , 1999, Nature Medicine.

[34]  D. Knowles,et al.  Biased Immunoglobulin G1 Isotype Responses Induced in Cattle with DNA Expressing msp1a of Anaplasma marginale , 1999, Infection and Immunity.

[35]  T. Schumacher,et al.  CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy , 1999, Nature Medicine.

[36]  L. Kwak,et al.  Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity , 1999, Nature Biotechnology.

[37]  S. Akira,et al.  Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.

[38]  D. Weiner,et al.  Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. , 1998, Journal of immunology.

[39]  J. Hansen,et al.  Comparisons of DNA‐mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type‐1 and hepatitis B virus , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[40]  R. Diez,et al.  Phase I study of VRCTC-310, a purified phospholipase A2 purified from snake venom, in patients with refractory cancer: safety and pharmacokinetic data , 1997, Anti-cancer drugs.

[41]  G. Weiner,et al.  Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Ulmer,et al.  Heterologous protection against influenza by injection of DNA encoding a viral protein. , 1993, Science.

[43]  R. Levy,et al.  Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. , 1992, The New England journal of medicine.

[44]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[45]  G. Acsadi,et al.  Direct gene transfer into mouse muscle in vivo. , 1990, Science.

[46]  N. Benvenisty,et al.  Direct introduction of genes into rats and expression of the genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[47]  T. Dubensky,et al.  Direct transfection of viral and plasmid DNA into the liver or spleen of mice. , 1984, Proceedings of the National Academy of Sciences of the United States of America.